Clyde W. Yancy MD, MSc discusses high-level treatment options for heart failure based on the ACC/AHA heart failure guidelines. He shares that heart failure is not inevitable but can be indeed prevented. He examines why the SGLT2-inhibitor story is exciting, how it came about and what the practitioner should do today with this new information.